Principal Street Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.22M Sell
58,971
-5,919
-9% -$829K 1.34% 17
2025
Q4
$7.96M Sell
64,890
-1,217
-2% -$148K 1.34% 17
2025
Q3
$7.34M Sell
66,107
-16,743
-20% -$1.9M 1.17% 19
2025
Q2
$9.19M Buy
82,850
+6,037
+8% +$642K 0.9% 21
2025
Q1
$8.61M Buy
76,813
+212
+0.3% +$21.9K 1.6% 11
2024
Q4
$7.08M Buy
76,601
+609
+0.8% +$54.8K 1.39% 17
2024
Q3
$6.36M Sell
75,992
-21,930
-22% -$1.67M 1.04% 25
2024
Q2
$6.72M Buy
97,922
+10,003
+11% +$668K 1.2% 35
2024
Q1
$6.27M Buy
87,919
+26,658
+44% +$2.05M 1.19% 48
2023
Q4
$4.96M Sell
61,261
-621
-1% -$48.3K 1.2% 35
2023
Q3
$4.64M Sell
61,882
-931
-1% -$71.6K 0.92% 33
2023
Q2
$4.84M Sell
62,813
-1,502
-2% -$120K 1.15% 36
2023
Q1
$5.34M Sell
64,315
-11,616
-15% -$962K 1.35% 28
2022
Q4
$6.52M Buy
75,931
+70,689
+1,349% +$5.6M 1.64% 5
2022
Q3
$324K Buy
5,242
+355
+7% +$22.4K 0.09% 155
2022
Q2
$302K Buy
4,887
+17
+0.3% +$1.05K 0.08% 162
2022
Q1
$290K Sell
4,870
-1,091
-18% -$69.7K 0.07% 185
2021
Q4
$432K Buy
5,961
+267
+5% +$18.4K 0.1% 152
2021
Q3
$398K Buy
5,694
+191
+3% +$13.4K 0.11% 134
2021
Q2
$379K Sell
5,503
-6,268
-53% -$419K 0.1% 150
2021
Q1
$761K Buy
11,771
+7,339
+166% +$473K 0.1% 135
2020
Q4
$258K Sell
4,432
-49,412
-92% -$2.98M 0.08% 156
2020
Q3
$3.4M Buy
53,844
+9,174
+21% +$636K 1.2% 44
2020
Q2
$3.44M Sell
44,670
-12,111
-21% -$928K 1.28% 45
2020
Q1
$4.25M Buy
56,781
+53,348
+1,554% +$3.69M 1.78% 30
2019
Q4
$223K Buy
+3,433
New +$224K 0.05% 185

Other funds holding GILD

Principal Street Partners's GILD Position: Q1 2026 in Review

Principal Street Partners reduced its Gilead Sciences (GILD) stake by 9.1% in Q1 2026, selling an estimated $829K and leaving 58,971 shares worth $8.22M. The position accounts for 1.34% of the portfolio, ranked #17.

Principal Street Partners first reported a position in GILD in Q4 2019 and has held it in 26 quarters since. The position peaked at $9.19M in Q2 2025. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Principal Street Partners held 58,971 shares of Gilead Sciences worth $8.22M as of Q1 2026.
  • Principal Street Partners sold 5,919 Gilead Sciences shares in Q1 2026, an estimated $829K.
  • Gilead Sciences made up 1.34% of Principal Street Partners's portfolio in Q1 2026, its #17 holding.
  • Principal Street Partners first reported a position in Gilead Sciences in Q4 2019 and has held it in 26 quarters since.
  • Principal Street Partners's Gilead Sciences position peaked at $9.19M in Q2 2025.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Principal Street Partners's 13F filing for Q1 2026, filed 15 May 2026.